|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.46 USD | -0.59% |
|
+2.58% | -2.49% |
| 05-13 | Supernus Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:40 PM | |
| 05-05 | Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.59% | +2.58% | +7.47% | -4.38% | -2.49% | +46.23% | +62.45% | +71.60% | +123.94% | 2.83B | |
| -1.22% | -2.56% | +3.74% | +1.75% | +17.37% | +47.04% | +12.35% | +59.30% | +108.19% | 309B | |
| +0.07% | -5.29% | +1.12% | +25.40% | +13.95% | +25.52% | -4.64% | -17.58% | +50.67% | 69.38B | |
| -3.08% | -5.67% | +8.09% | +12.36% | +13.22% | +32.22% | +104.18% | +67.51% | +739.21% | 9.33B | |
| -1.23% | +0.38% | +12.98% | +0.76% | +4.51% | +5.35% | +0.63% | -32.71% | +49.29% | 8.62B | |
| +2.74% | -4.85% | -10.34% | -15.57% | -33.87% | -12.15% | +9.28% | -35.62% | - | 4.16B | |
| +1.60% | -1.99% | +28.76% | +49.31% | +41.06% | +13.49% | +26.63% | -29.40% | - | 4.01B | |
| +1.63% | -2.28% | -10.69% | -26.97% | -39.06% | -37.27% | +26.85% | +28.31% | +60.39% | 3.33B | |
| +2.24% | -3.59% | +14.66% | -13.13% | -16.27% | +12.02% | -22.73% | +36.75% | - | 2.09B | |
| +2.44% | -2.19% | +13.27% | -8.60% | -5.07% | -11.37% | +28.31% | -32.77% | - | 1.77B | |
| +1.52% | -1.81% | -0.11% | -16.12% | -13.96% | -19.98% | -21.14% | -7.45% | -41.83% | 1.69B | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64B | |
| +6.64% | -0.11% | +50.58% | +38.16% | +51.25% | +88.80% | +154.19% | +43.91% | - | 1.41B | |
| +3.08% | -2.85% | +4.18% | -24.87% | -8.72% | -32.30% | -27.89% | - | - | 1.25B | |
| +3.47% | -6.75% | -8.71% | -32.86% | -37.18% | +52.97% | +20.81% | +27.38% | +418.47% | 1.1B | |
| -1.80% | +0.12% | +6.22% | -14.05% | -11.83% | +2.24% | +39.17% | +90.70% | +104.69% | 1.07B | |
| -1.93% | -3.71% | +18.29% | +38.88% | +116.50% | +135.28% | +1,026.46% | +547.96% | - | 1.02B | |
| +0.07% | +1.49% | +4.09% | -20.34% | -15.62% | +49.63% | -11.43% | -69.21% | -95.15% | 964M | |
| +3.10% | -0.92% | +2.42% | -25.28% | -38.30% | -38.74% | -25.72% | -35.77% | - | 885M | |
| +2.53% | 0.00% | +9.95% | -17.35% | -12.59% | -28.53% | -6.90% | -53.18% | -65.24% | 887M | |
| Average | +1.12% | -1.85% | +8.21% | -2.78% | +1.21% | +17.39% | +73.20% | +36.65% | +132.06% | 21.32B | |
| Weighted average by Cap. | -0.31% | -0.55% | +3.86% | +5.51% | +15.03% | +39.79% | +14.38% | +42.71% | +110.65% |
- Stock Market
- Stocks
- SUPN Stock
- Sector Supernus Pharmaceuticals, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
